Feng Bi

7.8k citations
128 papers · 6.1k · 6 hit papers · h-index 36

Impact in

  • Oncology top 1%
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • MicroRNA in disease regulation

Papers in

Feng Bi

124 papers receiving 6k citations

Feng Bi's Hit Papers

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023 2023 · 224 citations
2240+3+7Years since publication200400600

Peers

Feng Bi
Comparison fields: 5 of 120
  • Oncology 1.7k
  • Cancer Research 714
  • Hepatology 374
  • Pulmonary and Respiratory Medicine 1.1k
  • Psychiatry and Mental health 453
Replace Masahiro Yamamoto with:
Masahiro Yamamoto Japan
Koichi Okamoto Japan
Qiang Hu United States
Se Hyun Kim South Korea
Haiyan Wu China
Li Qun Zhou China
Jingjing Wu China
Xia Li China
Hui Miao United States
Yang Liu China
Feng Bi relative to Masahiro Yamamoto Japan Masahiro Yamamoto's profile →
Citations per field
00.5×2×4×6.5×
Masahiro Yamamoto · 1×
Citations per year

Countries citing papers authored by Feng Bi

Since Specialization
Citations

This map shows the geographic impact of Feng Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Bi more than expected).

Fields of papers citing papers by Feng Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Bi. The network helps show where Feng Bi may publish in the future.

Co-authors

The 25 scholars most cited alongside Feng Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Feng Bi Line = papers co-authored together Feng Bi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2015650
2
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
Hit paper breakdown →
2021488
3
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
Hit paper breakdown →
2021329
4
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
Hit paper breakdown →
2021314
5
Ferroptosis in the tumor microenvironment: perspectives for immunotherapy
Hit paper breakdown →
2021249
6
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
Hit paper breakdown →
2023224
7 2017212
8 2011152
9 2015151
10 2010145
11 2015141
12 2015139
13 2016129
14 2014125
15 2011109
16 2013107
17 2018107
18 201692
19 201992
20 201487

About Feng Bi

Feng Bi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Hepatology and Cell Biology, having authored 128 papers that have together received 6.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (23 papers), Gastric Cancer Management and Outcomes (13 papers), Cancer Immunotherapy and Biomarkers (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), MicroRNA in disease regulation (7 papers), Renal cell carcinoma treatment (6 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Functional Brain Connectivity Studies (5 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (714 citations), Hepatology (374 citations), Pulmonary and Respiratory Medicine (1.1k citations) and Psychiatry and Mental health (453 citations). Feng Bi has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Qiulin Tang, Hongwei Xia, Qiyong Gong, Xiaoqi Huang, Huanji Xu, Su Lui, Gongmin Zhu, Lijiao Pei, Meng Qiu and Yuxian Bai. Their work appears in journals such as Annals of Oncology, 癌症:英文版, Oncotarget, Medical Oncology and International Journal of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact